Access to antiretroviral treatment in the developing world: A framework, review and health systems research agenda

Therapy

Volumn 4, Issue 6, 2007, Pages 753-766

  Bärnighausen, Till ^a,b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Access; Antiretroviral treatment; Developing countries; Health systems; Review

Indexed keywords

ANTIRETROVIRUS AGENT;

CLINICAL COMPETENCE; CONCEPTUAL FRAMEWORK; DEVELOPING COUNTRY; DOSE CALCULATION; DRUG INDICATION; FETOPLACENTAL UNIT; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE NEED; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SERVICES RESEARCH; HIV EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION DISSEMINATION; LONG TERM CARE; PATIENT ATTITUDE; REVIEW;

EID: 38049123833     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.1586/14750708.4.6.753     Document Type: Review

References (134)

1. Adler MW: Antiretrovirals for developing world. Lancet 351(9098), 232 (1998).
2. Hogg RS, Yip B, Kully C et al.: Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ 160(5), 659-665 (1999).
3. Gulzar L: Access to health care. Image J. Nurs. Sch. 31(1), 13-19 (1999).
4. Ricketts TC, Goldsmith LJ: Access in health services research: the battle of frameworks. Nurs. Outlook 53, 274-280 (2005).
5. Liu C, Watts B, Litaker D: Access to and utilization of healthcare: the provider's role. Expert Rev. Pharmacoeconomies Outcomes Res. 6(6), 653-660 (2006).
6. Andersen RM: Behavioral Model of Families' Use of Health Services. Research Series No. 2. Center for Health Administration Studies, University of Chicago, IL, USA (1968).
7. Andersen RM: Revisiting the behavioral model and access to medical care: does it matter? J. Health Soc. Behav. 36(1), 1-10 (1995).
8. Penchansky R, Thomas JW: The concept of access: definition and relationship to consumer satisfaction. Med. Care 19(2), 127-140 (1981).
9. Boerma JT, Stanecki KA, Newell ML et al.: Monitoring the scale-up of antiretroviral therapy programs: methods to estimate coverage. Bull. World Health Organ. 84(2), 145-150 (2006).
10. Ghys PD, Brown T, Grassly NC et al.: The UNAIDS estimation and projection package: a software package to estimate and project national HIV epidemics. Sex. Tansm. Infect. 80(Suppl. 1), 15-19 (2004).
11. Ghys PD, Walker N, Garnett GP: Improving analysis of the size and dynamics of AIDS epidemics. Sex. Transm. Infect. 82(Suppl. 3), III1-III2 (2006).
12. White RG, Vynnycky E, Glynn JR et al.: HIV epidemic trend and antiretroviral treatment need in Karonga District, Malawi. Epidemiol. Infect. 135(6), 922-932 (2007).
13. + cell count distributions in African populations. J. Infect. Dis. 194(10), 1450-1458 (2006).
14. Stover J: A Computer Program for HIV/AIDS Projections and Examining the Social and Economic Impacts of AIDS. The Futures Group International, Washington, DC, USA (2007).
15. + lymphocyte counts in HIV-1-infected patients. Lancet 362 (9394), 1459-1460 (2003).
16. WHO, UNAIDS, United Nations Children's Fund: Towards Universal Access. Geneva, Switzerland (2007).
17. Bishai D, Colchero A, Durack DT: The cost effectiveness of antiretroviral treatment strategies in resource-limited settings. AIDS 21(10), 1333-1340 (2007).
18. Vijayaraghavan A, Efrusy MB, Mazonson PD, Ebrahim O, Sanne IM, Santas CC: Cost-effectiveness of alternative strategies for initiating and monitoring highly active antiretroviral therapy in the developing world. J. Acquir. Immune Defic. Syndr. 46(1), 91-100 (2007).
19. Orrell C, Harling G, Lawn SD et al.: Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited. Antivir. Ther. 12(1), 83-88 (2007).
20. Bertagnollo S, Soto-Ramirez L, Pilon R et al.: HIV-1 drug resistance surveillance using dried whole biood spots. Antivir Ther. 12(1), 107-113 (2007).
21. WHO: Progress on Global Access to HIV Antiretroviral Therapy. WHO, Geneva, Switzerland (2006).
22. Allen S, Karita E, N'gandu N, Tichacek A: The evolution of voluntary testing and counseling as an HIV prevention strategy In: Preventing HIV in Developing Countries. Springer, Berlin, Germany (2002).
23. de Cock KM, Bunnell R, Mermin J: Unfinished business - expanding HIV testing in developing countries. N. Engl. J. Med. 354(5), 440-442 (2006).
24. de Cock KM, Marum E, Mbori-Ngacha D: A serostatus-based approach to HIV/ AIDS prevention and care in Africa. Lancet 362, 1847-1849 (2003).
25. de Cock KM, Mbori-Ngacha D, Marum E: Shadow on the continent: public health and HIV/AIDS In Africa in the 21st Century. Lancet 360(9326), 67-72 (2002).
26. Kenyon K: Routine HIV testing: a view from Botswana. Health Hum. Rights 8(2), 21-23 (2005).
27. Department of Health: HIV and AIDS and STI Strangic Plan for South Africa, 2007-2011. Department of Health, Pretoria, South Africa (2007).
28. Mills EJ, Chong S: Lesotho embarks on universal HIV testing. HIV AIDS Policy Law Rev. 11(1), 27-28 (2006).
29. Weiser SD, Heisler M, Leiter K et al.: Routine HIV testing in Botswana: a population-based study on attitudes, practices, and human rights concerns. PLoS Med. 3(7). E261 (2005).
30. Jürgens R: 'Routinizing' HIV Testing in Low- and Middle-Income Countries - Background Paper. Public Health Program of the Open Society Institute, NY, USA (2006).
31. de Cock KM, Johnson AM: From exceptionalism to normalisation: a reappraisal of attitudes and practice around HIV testing. BMJ 316(7127), 290-293 (1998).
32. Bayer R: Clinical progress and the future of HIV exceptionalism. Arch. Intern. Med. 15(10), 1042-1048 (1999).
33. Bayer R, Fairchild AL: Changing the paradigm for HIV testing - the end of exceptionlism. N. Engl. J. Med. 355(7), 647-649 (2006).
34. Landman KZ, Thielman NM, Mgonja A et al.: Antiretroviral treatment literacy among HIV voluntary counseling and testing clients in Moshi, Tanzania, 2003-2005. J. Int. Assoc. Physicians AIDS Care (Chic. Ill.) 6(1), 24-26 (2007).
35. Ramchandani SR, Mehta SH, Saple DG et al.: Knowledge, attitudes, and practices of antiretroviral therapy among HIV-infecred adults attending private and public clinics in India. AIDS Patient Care STDS 21(2), 129-142 (2007).
36. Barnighausen T, Tanser F, Newell M: Determinants of knowledge of access to antiretroviral treatment in rural KwaZulu-Natal, South Africa. Presented at: Astra-Zeneca College of Health Sciences Conference. University of KwaZulu-Natal, Durban, South Africa (2007).
37. Cooper DA, Merigan TC: Clinical treatment. AIDS 10(Suppl. A), S133-S134 (1996).
38. Ebrahim SH, Anderson JE, Weidie P, Purcell DW: Race/ethnic disparities in HIV testing and knowledge about treatment for HIV/AIDS: United States, 2001. AIDS Patient Care STDS 18(1), 27-33 (2004).
39. Whetten K. Leserman J, Whetten R et al.: Exploring lack of trust in care providers and the government as a barrier to health service use. Am. J. Public Health 96(4), 716-721 (2006).
40. Bodenlos JS, Grothe KB, Whitehead D, Konkle-Parker DJ, Jones GN. Brantley PI: Attitudes toward health care providers and appointment attendance in HIV/AIDS patients. J. Assoc. Nurses AIDS Care 18(3), 65-73 (2007).
41. Banda Y, Chapman V, Goldenberg RL et al.: Use of traditional medicine among pregnant women in Lusaka, Zambia. J. Altern. Complement. Med. 13(1), 123-127 (2007).
42. Mitchell SK, Kelly KJ, Potgieter FE, Moon MW: Assessing social preparedness for antiretroviral therapy in a generalized AIDS epidemic: a diffusion of innovations approach. AIDS Behav. (2007) (Epub ahead of print).
43. Babb DA, Pemba L, Seatlanyane P, Charalambous S, Churchyard GJ, Grant AD: Use of traditional medicine by HIV-infected individuals in South Africa in the era of antiretroviral therapy. Psychol. Health Med. 12(3), 314-320 (2007).
44. Plummer ML, Mshana G. Wamoyi J et al.: 'The man who believed he had AIDS was cured': AIDS and sexually-transmitted infection treatment-seeking behaviour in rural Mwanza, Tanzania. AIDS Care 18(5). 460-466 (2006).
45. Homsy J, King R, Balaba D, Kabatesi D: Traditional health practitioners are key to scaling up comprehensive care for HIV/AIDS in sub-Saharan Africa. AIDS 18(12). 1723-1725 (2004).
46. Homsy J, King R. Tenywa J, Kyeyune P, Opio A, Balaba D: Defining minimum standards of practice for incorporating African traditional medicine into HIV/AIDS prevention, care, and support: a regional initiative in eastern and southern Africa. J. Altern. Complement. Med. 10(5). 905-910 (2004).
47. Wanyama J, Castelnuovo B, Wandera B et al.: Belief in divine heating can be a barrier to antiretroviral therapy adherence in Uganda. AIDS 21(11), 1486-1487 (2007).
48. Muko KN, Ngwa VC, Chigang LC, Ngwa IG, Melbdrg A, Shu EN: Willingness to pay for treatment with highly active antiretroviral (HAART) drugs: a rural 6ase study in Cameroon. Sahara J. 1(2), 107-113 (2004).
49. Larsson EC, Okong P, Thorson A, Ekström AM: Antiretroviral treatment of HIV in Uganda: a comparison of three different delivery models in a single hospital. Trans. R. Soc. Trop. Med. Hyg. 101(9), 895-892 (2007).
50. Mshana GH, Wamoyi J, Busza J et al.: Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS 20(9), 649-657 (2006).
51. Abadia-Barrero CE, Castro A: Experiences of stigma and access to HAART in children and adolescents living with HIV/AIDS in Brazil. Soc. Sci. Med. 62(5), 1219-1228 (2006).
52. Meng X, Anderson AF, Hou X et al.: A pilot project for the effective delivery of HAART in rural China. AIDS Patient Care STDS 20(3), 213-219 (2006).
53. Wilson DP, Blower S: How far will we need to go to reach HIV-irdected people in rural South Africa? BMC Med. 5, 16 (2007).
54. Rosen S, Ketlhapile M, Sanne I, DeSilva MB: Cost to patients of obtaining treatment for HIV/AIDS in South Africa. S. Afr. Med. J. 97(7), 524-529 (2007).
55. Hardon AP, Akurut D, Comoro C et al.: Hunger, waiting time, and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care 19(5), 658-665 (2007).
56. Muula AS: The lessons learned from paying antiretroviral therapy in Malawi. J. Int. Assoc. Physicians AIDS Care (Chic. Ill.). 6(2), 94 (2007).
57. Kitajima T. Kobayashi Y, Chaipah W et al.: Access to antiretroviral therapy among HIV/AIDS patients in Khon Kaen Province, Thailand. AIDS Care 17(3), 359-366 (2005).
58. Msellati P, Juillet-Amari A, Prudhomme J et al.: Socio-econon-dc and health characteristics of HIV-infected patients seeking care in relation to access to the Drug Access Initiative and to antiretroviral treatment in Cote d'Ivoire. AIDS 17(Suppl. 3). S63-S68 (2003).
59. Luo C: Achievable standard of care in low-resource settings. Ann. NY Acad. Sci. 918, 179-187 (2000).
60. Abadia-Barrero CE: Growing up in a world with AIDS: social advantages of having AIDS in Brazil. AIDS Care 14(3), 417-423 (2002).
61. Muula AS: On socio-cultural factors and barriers to HIV prevention for Malawi women. Women Health 42(4), 123-125: author reply 127-129 (2005).
62. Lyttleton C, Beesey A, Sitthikriengkrai M: Expanding community through ARV provision in Thailand. AIDS Care 19(Suppl. 1), S44-S53 (2007).
63. Muula A: Ethical and programmatic challenges in antiretroviral scaling-up in Malawi: challenges in meeting the World Health Organization's 'treating 3 million by 2005' initiative goals. Croat. Med. J. 45, 415-421 (2004).
64. Muula AS, Maseko FC: Identification of beneficiaries of free anti-retroviral drugs in Malawi: a community consensus process. AIDS Care 19(5), 653-657 (2007).
65. Daniels N: How to Achieve Fair Distribution of ARTs in 3 by 5. Fair Process and Legitimacy in Patient Selection. Background Paper for the Consultation on Ethics and Equitable Access to Treatment and Care for HIV/AIDS. WHO, Geneva, Switzerland (2004).
66. Daniels N, Sabin J: Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers. Philos Public Aff. 26, 303-350 (1997).
67. Macklin R: Ethics and Equity in Access to HIV Treatment - 3 by 5 Initiative. Fair Process and Legitimacy in Patient Selection Background Paper for the Consultation an Ethics and Equitable Access to Tratment and Care for HIV/AIDS. WHO, Geneva. Switzerland (2004).
68. Marchand S, Wikler D, Landsman B: Class, health, and justice. Milbank Q 76. 449-467 (1998).
69. Bennett S, Chanfreau C: Approaches to rationing antiretroviral treatment: ethical and equity implications. Bull. World Health Organ. 83(7), 541-547 (2005).
70. Wilson D, Blower S: Designing equitable antiretroviral allocation strategies In resource-constrained countries. PLoS Med. 2(2), E50 (2005).
71. Médecins Sans Frontiès: Help Wanted - Confronting the Health Care Worker Crisis to Expand Access to HIV/AIDS Treatment: MSF Experience in Southern Africa. Médecins Sans Frontières, Johannesburg, South Africa (2007).
72. Institute of Medicine: PEPFAR Implementation: Progress and Promise. National Academic Press, Washington, DC, USA (2007).
73. Clark J: HIV programs in poor countries lack health workers. BMJ 333(7565), 412 (2006).
74. Habte D, Dussault G, Dovlo, D: Challenges confronting the health workforce in sub-Saharan Africa. World Hosp. Health Serv. 40(2), 23-26 (2004).
75. Hosselnipour MC, Kazembe PN, Sanne IM. van der Horst CM: Challenges in delivering antiretroviral treatment in resource poor countries. AIDS 16(Suppl. 4), S177-S187 (2002).
76. Ooms G, van Damme W, Temmerman M: Medicines without doctors: why the global fund must fund salaries of health workers to expand AIDS treatment. PLoS Med. 4(4), E128 (2007).
77. van Damme W, Kegels G: Health system strengthening and scaling up antiretroviral therapy: the need for context-specific delivery models: comment on Schneider et al.: Reprod. Health Matters 14(27), 24-26 (2006).
78. van Damme W, Kober K, Laga M: The real challenges for scaling up ART in sub-Saharan Africa. AIDS 20 (5), 653-656 (2006).
79. Bärnighausen T, Bloom DE: "Conditional Scholarships" for HIV/AIDS Health Educating and Retaining the Workforce to Provide Antiretroviral Treatment in sub-Saharan Africa. National Bureau of Economic Research Working Paper 13396 (2007).
80. Bärnighausen T, Bloom DE, Humair S: Human resources for treating HIV/AIDS: needs, capacities, and gaps. AIDS Patient Care SYDS (2007) (Epub ahead of print).
81. USAID Bureau for Africa: The Health Sector Human Resource Crisis in Africa: An Issues Paper. USAID, Washington, DC, USA (2003).
82. Joint Learning Initiative for Human Resources for Health: Human Resource for Health: Overcoming the Crisis. Harvard University Press, MA, USA (2004).
83. WHO: World Health Report 2006: Working Together for Health. WHO, Geneva, Switzerland (2006).
84. Vujicic M, Zurn P, Diallo K, Adams O, Dal Poz MR: 'The role of wages in the migration of health care professionals from developing countries. Hum. Resour. Health 2(1), 3 (2004).
85. WHO: Migration of Health Professionals in Six Countries: a Synthesis Report. WHO, Regional Office for Africa, Brazzaville, Republic of the Congo (2003).
86. Hirschhorn LR. Oguda L, Fullem A, Dreesch N. Wilson P: Estimating health workforce needs for antiretroviral therapy in resource-limitted settings. Hum. Resour. Health 4, 1 (2006).
87. Miles K, Clutterbuck DJ, Seitio, O, Sebego, M, Riley A: Antiretroviral treatment roll-out in a resource-constratned setting: capitalizing on nursing resources in Botswana. Bull. World Health Organ. 85(7), 555-560 (2007).
88. Mukherjee JS, Eustache FE: Community health workers as a cornerstone for integrating HIV and primary healthcare. AIDS Care 19 (Suppl. 1), S73-S82 (2007).
89. Schneider H, Blaauw D, Gilson L, Chabikuli N, Goudge J: Health systems and access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges. Reprod Health Matters 14(27), 12-23 (2006).
90. WHO, UNAIDS: Progress on Global Access to HIV Antiretroviral Therapy: a Report on '3 by 5' and Beyond. WHO, Geneva, Switzerland (2006).
91. Zolfo M, Lynen L, Dierckx J, Colebunders R: Remote consultations and HIV/ AIDS continuing education in low-resource settings. Int. J. Med. Inform. 75(9). 633-637 (2006).
92. Zolfo M, Arnould L. Huyst V, Lynen L: Telemedicine for HIV/AIDS care in low resource settings. Stud. Health Technol. Inform. 114, 18-22 (2005).
93. Clevenbergh P. van der Borght SF, van Cranenburgh K et al.: Database-supported teleconferencing: an additional clinical mentoring tool to awn a multinational company HIV/AIDS treatment program in Africa. HIV Clin Trials 7(5), 255-262 (2006).
94. Gilks CF, Crowley S, Ekpini R et al.: 'The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 368(9534), 505-510 (2006).
95. Tierney WM, Beck EJ, Gardner RM et al.: Viewpoint: a pragmatic approach to constructing a minimum data set for care of patients with HIV in developing countries. J. Am. Med. Inform. Assoc. 13(3), 253-260 (2006).
96. Starfield B: Primary Care: Balancing Health Needs, Services and Technology. Oxford University Press. NY. USA (1998).
97. Friedland G, Williams H: Attaining higher goals in HIV treatment: the central importance of adherence. AIDS 13(Suppl. 1), S61-S72 (1999).
98. Chesney M: Adherence to HAA1Zr regimens. AIDS Patient Care STDS 17(4), 169-177 (2000).
99. Stone V: Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from clinical research and practice. Clin. Infect. Dis. 33, 865-872 (2001).
100. Paterson DL, Swindells S. Mohr J et al.: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann. Intern. Med. 133(1), 21-30 (2000).
101. Bangsberg DR, Hecht FM, Charlebois ED et al.: Adherence to protease, inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 14(4), 357-366 (2000).
102. García de Olalla P, Knobei H, Carmona A, Guelar A, López-Colomés JL, Caylà JA: Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J. Acquir Immune Defic. Syndr. 30(1), 105-110 (2002).
103. Hogg RS, Heath K, Bangsberg D et al.: Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS 16(7), 1051-1058 (2002).
104. Mills EJ, Nachega JB, Buchan I et al.: Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 296(6), 679-690 (2006).
105. Rosen S, Fox MP, Gill CJ: Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 4(10), E298 (2007).
106. Marazzi MC. Guidotti G, Liotta G, Palombi L: DREAM: An Integrated Faith-Based Initiative to Treat HIV/AIDS in Mozambique. WHO, Geneva, Switzerland (2005).
107. Nacher M, El Guedj M, Vaz T et al.: Risk factors for follow-up interruption of HIV patients in French Guiana. Am. J. Trop. Med. Hyg. 74(5), 915-917 (2006).
108. Karcher H, Omondi A, Odera I Kunz A. Harms G: Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop. Med. Int. Health 12(5), 687-694 (2007).
109. Weidle FJ, Wamai N, Solberg P et al.: Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet 368(9547), 1587-1594 (2006).
110. Safran C, Rind DM, Davis RB et al.: Guidelines for management of HIV infection with computer-based patient's record. Lancet 346(8971), 341-346 (1995).
111. Fraser HS, Jazayeri D, Nevil P et al.: An information system and medical record to support HIV treatment in rural Haiti. BMJ 329(7475), 1142-1146 (2004).
112. Fraser HS, Allen C, Bailey C, Douglas G, Shin S, Blaya J: Information systems for patient follow-up and chronic management of HIV and tuberculosis: a life-saving technology in resource-poor areas. J. Med. Internet Res. 9(4), E29 (2007).
113. Luo C, Akwara P, Ngongo N et al.: Global progress in PMTCT and paediatric HIV care and treatment in low- and middle-income countries in 2004-2005. Reprod. Health Matters 15 (30), 179-189 (2007).
114. Fowler MG, Lampe MA, Jamieson DJ, Kourtis AP, Rogers MF: Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions. Am. J. Obstet. Gynecol. 197(Suppl. 3), S3-S9 (2007).
115. Abrams, EJ. Myer L, Rosenfield A, El-Sadr WM: Prevention of mother-to-child transmission services as a gateway to family-based human immunodeficiency virus care and treatment in resource-limited settings: rationale and international experiences. Am. J. Obstet. Gynecol. 197(Suppl. 3), S101-S106 (2007).
116. Bolu OO, Allread V, Creek T et al.: Approaches for scaling up human immunodeficiency virus testing and counseling in prevention of mother-to-ahild human immunodeficiency virus transmission settings in resource-limited countries. Am. J. Obstet. Gynecol. 197(Suppl. 3), S83-S89 (2007).
117. Medley A. Garcia-Moreno C, McGill S, Maman S: Rates barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programs. Bull. World Health Organ. 82(4), 299-307 (2004).
118. Havens PL, Gibb DM: Increasing antiretroviral drug access for children with HIV infection. Pediatrics 119(4), 838-845 (2007).
119. King SM: Evaluation and treatment of the human immunodeficiency virus-1 - exposed infant Pediatrics 114(2), 497-505 (2004).
120. Sherman GG, Cooper PA, Coovadia AH et al.: Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings. Pediatr Infect. Dis. J. 24(11), 993-997 (2005).
121. Prendergast A, Tudor-Williams G, Jeena P, Burchett S, Goulder P: International perspectives. progress, and future challenges of paediatric HIV infection. Lancet 370(9581), 68-80 (2007).
122. Kline MW: Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment. Pediatrics 117(4), 1388-1393 (2006).
123. Daniels ZM, Vanleit BJ, Skipper BJ, Sanders ML, Rhyne RL: Factors in recrulting and retaining health professionals for rural practice. J. Rural Health 23(1), 62-71 (2007).
124. World Organisation of Family Doctors: Training for Rural General Practice. World Organisation of Family Doctors, Singapore (1995).
125. Kotzee TJ, Couper ID: What interventions do South African qualified doctors think will retain them in rural hospitals of the Limpopo province of South Africa? Rural Remote Health 6(3), 581 (2006).
126. Bogetic Z, Fedderke JW: International Benchmarking of Infrastructure Performance in the Southern African Customs Union Countries. World Bank Policy Research Working Paper Series. World Bank, Washington, USA (2006).
127. WHO: Enumeration of CD4 T Lymphocytes. WHO Regional Office for South-East Asia, New Dehli, India (2006).
128. Bardgett HP, Dixon M, Beeching NJ: Increase in hospital mortality from non-communicable disease and HIV-related conditions in Bulawayo, Zimbabwe; between 1992 and 2000. Trop. Doct. 36(3), 129-131 (2006).
129. Dedicoat M, Grimwade K, Newton R, Gilks C: Changes In the patient population attending a primary health care clinic in rural South Africa between 1991 and 2001. S. Afr. Med. J. 93(10), 777-778 (2003).
130. Floyd K, Reid RA, Wilkinson D, Gilks CF: Admission trends in a rural South African hospital during the early years of the HIV epidemic. JAMA 282(11), 1087-1091 (1999).
131. Harling G, Orrell C, Wood R: Healthcare utilization of patients accessing an African national treatment program. BMC Health Serv. Res. Res. 7, 80 (2007).
132. Department for International Development and Her Majesty's Treasury: International Finance Facility: A Technical Note. HM Treasury, Norwich, UK (2003).
133. Department for International Development and Her Majesty's Treasury: International Finance Facility Propasal - April 2004 HM Treasury, Norwich, UK (2004).
134. Sanne I, van der Horst C: Research as a path to wide-scale implementation of antiretroviral therapy in Africa. J. HIV Ther. 9(3), 65-68 (2004).